{
    "nct_id": "NCT03070236",
    "official_title": "PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions",
    "inclusion_criteria": "Patients treated at DUMC, DFCI, MDACC, MGH, NWH, or DFCI @ SSH with a diagnosis of DCIS, LCIS, ADH, or ALH who are also:\n\n* Age 18 or more at index diagnosis\n* Diagnosed with DCIS, LCIS, ADH, or ALH between January 1, 2012 and June 30, 2017\n* Able to read either English or Spanish and able to provide written (via paper), or on-line informed consent\n* Treated and followed at one of the study sites (including affiliated network sites) and for whom treatment and surveillance data are available, for at least 1 year of follow up after date of diagnosis\n* Participants with bilateral synchronous or metachronous disease (DCIS, LCIS, ADH, ALH) are eligible\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Ever had a diagnosis of invasive or microinvasive breast cancer\n* DCIS prior to index lesion or history of progressive/recurrent DCIS after treatment\n* Other cancers (excluding non-melanoma skin cancer) diagnosed within 5 years prior to index lesion, including concurrent invasive cancer diagnosis and up to the present time of participant's approach to invitation into the study\n* Patients identified by treating physician as being unsuitable for contact",
    "miscellaneous_criteria": ""
}